MedPath

Intrapace, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Safety Evaluation of the LGL102 in Obese Subjects Treated With OMS102

Not Applicable
Completed
Conditions
Obesity
Morbid Obesity
First Posted Date
2012-02-28
Last Posted Date
2012-02-28
Lead Sponsor
IntraPace, Inc
Target Recruit Count
34
Registration Number
NCT01539850
Locations
🇩🇪

Wolfart Klinik, Graefelfing, Germany

🇩🇪

Stadtkrankenhaus Schwabach, Schwabach, Germany

🇩🇪

Chirurgische Klinik und Poliklinik I Zentrum für Operative Medizin, Würzburg, Germany

Abiliti™ Treatment in Obese Subjects

Not Applicable
Conditions
Obesity
Morbid Obesity
First Posted Date
2011-10-07
Last Posted Date
2011-10-31
Lead Sponsor
IntraPace, Inc
Target Recruit Count
165
Registration Number
NCT01448785
Locations
🇫🇷

Polyclinique de Rillieux, Clinique Lyon-Nord, RILLIEUX Cedex, France

🇩🇪

MIC Ev. Krankenhaus Hubertus, Berlin, Germany

🇩🇪

SRH Wald-Klinikum Gera, Gera, Germany

and more 12 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.